Clinical Trial Update: Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating vorinostat with temozolomide and radiation for newly diagnosed glioblastoma multiforme has completed (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Radiation therapy
• Temozolomide (Temozolomide)
• Vorinostat (vorinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-05-13